Variant report

Variant	nsv877758
Chromosome Location	chr3:162287573-162521339
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr3:162387319-162387469	K562	blood:	n/a	n/a
2	ATF2	chr3:162458859-162459451	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr3:162458852-162459444	H1-hESC	embryonic stem cell:	n/a	n/a
4	BATF	chr3:162426813-162426972	GM12878	blood:	n/a	n/a
5	BRCA1	chr3:162343607-162343624	Hela-S3	cervix:	n/a	n/a
6	CBX3	chr3:162437445-162437946	HCT-116	colon:	n/a	n/a
7	CEBPB	chr3:162363967-162364264	HepG2	liver:	n/a	chr3:162364112-162364123 chr3:162364019-162364030
8	CEBPB	chr3:162493943-162494295	H1-hESC	embryonic stem cell:	n/a	n/a
9	CEBPB	chr3:162447411-162447959	A549	lung:	n/a	n/a
10	CEBPB	chr3:162375783-162376266	MCF-7	breast:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
11	CEBPB	chr3:162375840-162376163	A549	lung:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
12	CEBPB	chr3:162493941-162494308	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr3:162463221-162463465	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr3:162493987-162494268	A549	lung:	n/a	n/a
15	CEBPB	chr3:162447443-162447905	IMR90	lung:	n/a	n/a
16	CEBPB	chr3:162375773-162376159	MCF-7	breast:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
17	CEBPB	chr3:162375820-162376163	HepG2	liver:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
18	CEBPB	chr3:162490538-162490834	HepG2	liver:	n/a	chr3:162490691-162490702
19	CEBPB	chr3:162491565-162491768	A549	lung:	n/a	n/a
20	CEBPB	chr3:162446775-162447096	IMR90	lung:	n/a	chr3:162446911-162446922
21	CEBPB	chr3:162446780-162447056	HepG2	liver:	n/a	chr3:162446911-162446922
22	CEBPB	chr3:162446794-162447048	Hela-S3	cervix:	n/a	chr3:162446911-162446922
23	CEBPB	chr3:162318673-162319181	HepG2	liver:	n/a	chr3:162318771-162318782 chr3:162318770-162318783 chr3:162318770-162318783 chr3:162318770-162318781 chr3:162318772-162318781
24	CEBPB	chr3:162395700-162395948	A549	lung:	n/a	n/a
25	CEBPB	chr3:162407165-162407420	HepG2	liver:	n/a	n/a
26	CEBPB	chr3:162493953-162494306	IMR90	lung:	n/a	n/a
27	CEBPB	chr3:162397582-162397594	A549	lung:	n/a	n/a
28	CEBPB	chr3:162446913-162446930	H1-hESC	embryonic stem cell:	n/a	n/a
29	CEBPB	chr3:162476765-162477042	HepG2	liver:	n/a	chr3:162476875-162476886
30	CEBPB	chr3:162375910-162376151	ECC-1	luminal epithelium:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
31	CEBPB	chr3:162364026-162364261	Hela-S3	cervix:	n/a	chr3:162364112-162364123
32	CEBPB	chr3:162363990-162364207	A549	lung:	n/a	chr3:162364112-162364123 chr3:162364019-162364030
33	CEBPB	chr3:162375805-162376171	Hela-S3	cervix:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
34	CEBPB	chr3:162426766-162427111	A549	lung:	n/a	n/a
35	CEBPB	chr3:162375834-162376167	IMR90	lung:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
36	CEBPB	chr3:162328054-162328397	H1-hESC	embryonic stem cell:	n/a	n/a
37	CEBPB	chr3:162458978-162459479	H1-hESC	embryonic stem cell:	n/a	n/a
38	CEBPB	chr3:162447548-162447825	A549	lung:	n/a	n/a
39	CEBPB	chr3:162447493-162447822	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr3:162446791-162447068	A549	lung:	n/a	chr3:162446911-162446922
41	CEBPB	chr3:162318973-162319104	HepG2	liver:	n/a	n/a
42	CEBPB	chr3:162476766-162477058	A549	lung:	n/a	chr3:162476875-162476886
43	CEBPB	chr3:162476750-162477034	IMR90	lung:	n/a	chr3:162476875-162476886
44	CEBPB	chr3:162323772-162323878	H1-hESC	embryonic stem cell:	n/a	n/a
45	CEBPB	chr3:162318597-162318906	IMR90	lung:	n/a	chr3:162318771-162318782 chr3:162318770-162318783 chr3:162318770-162318783 chr3:162318770-162318781 chr3:162318772-162318781
46	CHD2	chr3:162492211-162492255	H1-hESC	embryonic stem cell:	n/a	n/a
47	CTCF	chr3:162383160-162383310	HEK293	kidney:	n/a	n/a
48	CTCF	chr3:162517800-162517950	AG04449	skin:	n/a	n/a
49	CTCF	chr3:162495033-162495175	HepG2	liver:	n/a	n/a
50	CTCF	chr3:162495000-162495150	HCM	heart:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:162421027-162421077	HAEpiC	amniotic membrane:	n/a
2	chr3:162317560-162317610	HRCEpiC	kidney:	n/a
3	chr3:162421027-162421077	NH-A	brain:	n/a
4	chr3:162420994-162421044	HCPEpiC	choroid plexus:	n/a
5	chr3:162421027-162421077	K562	blood:	n/a
6	chr3:162421027-162421077	AG09309	skin:	n/a
7	chr3:162421027-162421077	A549	lung:	n/a
8	chr3:162420994-162421044	PANC-1	pancreas:	n/a
9	chr3:162420994-162421044	Hela-S3	cervix:	n/a
10	chr3:162420994-162421044	GM12891	blood:	n/a
11	chr3:162421027-162421077	Caco-2	colon:	n/a
12	chr3:162420994-162421044	AG10803	skin:	n/a
13	chr3:162421027-162421077	HL-60	blood:	n/a
14	chr3:162420994-162421044	HCM	heart:	n/a
15	chr3:162317560-162317610	AG04450	lung:	fetal
16	chr3:162421027-162421077	PANC-1	pancreas:	n/a
17	chr3:162421027-162421077	HUVEC	blood vessel:	n/a
18	chr3:162421027-162421077	HEK293	kidney:	embryo
19	chr3:162421027-162421077	AG04450	lung:	fetal
20	chr3:162421027-162421077	CMK	blood:	n/a
21	chr3:162317560-162317610	HL-60	blood:	n/a
22	chr3:162420994-162421044	MCF-7	breast:	n/a
23	chr3:162420994-162421044	SKMC	muscle:	n/a
24	chr3:162421027-162421077	SKMC	muscle:	n/a
25	chr3:162421027-162421077	LNCaP	prostate:	n/a
26	chr3:162420994-162421044	T-47D	breast:	n/a
27	chr3:162317560-162317610	Hela-S3	cervix:	n/a
28	chr3:162317560-162317610	HNPCEpiC	eye:	n/a
29	chr3:162420994-162421044	HepG2	liver:	n/a
30	chr3:162420994-162421044	HUVEC	blood vessel:	n/a
31	chr3:162421027-162421077	AG09319	gingival:	n/a
32	chr3:162421027-162421077	GM12878	blood:	n/a
33	chr3:162317560-162317610	LNCaP	prostate:	n/a
34	chr3:162420994-162421044	HL-60	blood:	n/a
35	chr3:162317560-162317610	K562	blood:	n/a
36	chr3:162317560-162317610	HRE	kidney:	n/a
37	chr3:162420994-162421044	K562	blood:	n/a
38	chr3:162420994-162421044	PrEC	prostate:	n/a
39	chr3:162317560-162317610	HCF	heart:	n/a
40	chr3:162421027-162421077	AoSMC	blood vessel:	n/a
41	chr3:162317560-162317610	PANC-1	pancreas:	n/a
42	chr3:162317560-162317610	SKMC	muscle:	n/a
43	chr3:162317560-162317610	GM12878	blood:	n/a
44	chr3:162317560-162317610	HRPEpiC	eye:	n/a
45	chr3:162421027-162421077	ECC-1	luminal epithelium:	n/a
46	chr3:162420994-162421044	SK-N-MC	brain:	n/a
47	chr3:162421027-162421077	HCPEpiC	choroid plexus:	n/a
48	chr3:162421027-162421077	BJ	skin:	n/a
49	chr3:162420994-162421044	BE2_C	brain:	n/a
50	chr3:162421027-162421077	NB4	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr3:162394370..162397355-chr3:162401132..162403109,2	MCF-7	breast:
2	chr3:162367684..162370185-chr3:162370811..162372665,2	MCF-7	breast:
3	chr3:162471864..162474454-chr3:162482441..162485010,2	MCF-7	breast:
4	chr3:162449508..162452375-chr3:162459605..162462257,2	MCF-7	breast:
5	chr3:162367684..162370185-chr3:162370811..162372665,2	MCF-7	breast:
6	chr3:162268890..162270552-chr3:162314764..162316650,2	MCF-7	breast:
7	chr3:162494680..162495563-chr3:162760633..162761552,3	MCF-7	breast:
8	chr3:162307801..162310469-chr3:162314134..162316904,3	MCF-7	breast:
9	chr3:162399486..162401021-chr3:162401571..162403144,2	MCF-7	breast:
10	chr3:162468849..162471720-chr3:162897232..162899564,2	K562	blood:
11	chr3:162307801..162310469-chr3:162314134..162316904,3	MCF-7	breast:
12	chr3:162486396..162487274-chr3:162497260..162497768,2	MCF-7	breast:
13	chr3:162118223..162119105-chr3:162517137..162517997,2	MCF-7	breast:
14	chr3:162471864..162474454-chr3:162482441..162485010,2	MCF-7	breast:
15	chr3:162475543..162478495-chr3:162480272..162482533,2	MCF-7	breast:
16	chr15:52605031..52607219-chr3:162453213..162454978,2	MCF-7	breast:
17	chr3:162399486..162401021-chr3:162401571..162403144,2	MCF-7	breast:
18	chr3:162475543..162478495-chr3:162480272..162482533,2	MCF-7	breast:
19	chr3:162411048..162413287-chr3:162414403..162417401,2	MCF-7	breast:
20	chr3:162486396..162487274-chr3:162497260..162497768,2	MCF-7	breast:
21	chr3:162449508..162452375-chr3:162459605..162462257,2	MCF-7	breast:
22	chr3:162411048..162413287-chr3:162414403..162417401,2	MCF-7	breast:
23	chr3:162394370..162397355-chr3:162401132..162403109,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-OTOL1-2	chr3:162442527-162442700	NONHSAT093026
2	lnc-OTOL1-8	chr3:162441830-162442283	NONHSAT093025
3	lnc-OTOL1-8	chr3:162455438-162455542	NONHSAT093025
4	lnc-OTOL1-2	chr3:162443543-162443656	NONHSAT093026

Variant related genes	Relation type
ENSG00000243044	TF binding region
ENSG00000243044	CpG island

Extended variants
information (count: 8333 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:8333 , 50 per page) page: 1 2 3 4 5 6 7 ... 167

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9816189	chr3:162287573-162287574	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs559198439	chr3:162287652-162287653	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs530808277	chr3:162287656-162287657	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs189528940	chr3:162287664-162287665	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs369634790	chr3:162287726-162287727	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs180922077	chr3:162287782-162287783	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs139477759	chr3:162287786-162287787	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs566521160	chr3:162287793-162287794	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs112723585	chr3:162287928-162287929	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs555899184	chr3:162287929-162287930	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs76854041	chr3:162287953-162287954	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs145094911	chr3:162288023-162288024	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs558058643	chr3:162288055-162288056	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs185331617	chr3:162288059-162288060	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs190237925	chr3:162288060-162288061	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs183570739	chr3:162288125-162288126	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs376522487	chr3:162288159-162288160	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs139814698	chr3:162288194-162288195	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs548724747	chr3:162288195-162288196	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs74489710	chr3:162288201-162288202	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs376312119	chr3:162288202-162288203	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs188550580	chr3:162288215-162288216	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs542779384	chr3:162288236-162288237	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs76600793	chr3:162288262-162288263	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs563290302	chr3:162288270-162288271	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs544513705	chr3:162288271-162288272	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs542836382	chr3:162288501-162288502	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs572052437	chr3:162288505-162288506	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs192244503	chr3:162288521-162288522	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs183663949	chr3:162288536-162288537	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs566366231	chr3:162288553-162288554	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs528946932	chr3:162288602-162288603	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs115259960	chr3:162288611-162288612	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs569412455	chr3:162288612-162288613	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs538097278	chr3:162288658-162288659	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs551649470	chr3:162288681-162288682	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs16850727	chr3:162288694-162288695	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs139529932	chr3:162288695-162288696	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs7635755	chr3:162288726-162288727	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs372486177	chr3:162288732-162288733	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs16850734	chr3:162288775-162288776	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs9841809	chr3:162288784-162288785	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs78681652	chr3:162288809-162288810	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs7646114	chr3:162288818-162288819	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs544379401	chr3:162288819-162288820	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs74547757	chr3:162288820-162288821	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs73163566	chr3:162288844-162288845	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs144153547	chr3:162288874-162288875	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs560077736	chr3:162288882-162288883	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs528911050	chr3:162288897-162288898	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	16608533	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-small cell lung cancer	19010865	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16547154	CNVD
Breast cancer	21364760	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Prostate cancer	16573809	CNVD
Breast cancer	21785460	CNVD
Sudden cardiac death	19188705	CNVD
Mantle cell lymphoma	19029149	CNVD
Malformation	19546859	CNVD
Schizophrenia	19546859	CNVD
Breast cancer	17133270	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
epilepsy	18472482	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Myxofibrosarcoma	16751306	CNVD
Parkinson disease	21907011	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Ovarian cancer	21781307	CNVD
Bladder cancer	21909424	CNVD
Chordoma	21215367	CNVD

Chromatin state (count:563 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:162278800-162291600	Weak transcription	Dnd41	blood
2	chr3:162287000-162287600	Enhancers	HepG2	liver
3	chr3:162287000-162287800	Enhancers	Fetal Lung	lung
4	chr3:162287000-162287800	Enhancers	Rectal Mucosa Donor 31	rectum
5	chr3:162287000-162288000	Enhancers	Fetal Intestine Large	intestine
6	chr3:162287200-162288000	Enhancers	Rectal Mucosa Donor 29	rectum
7	chr3:162287400-162287600	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr3:162287600-162287800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr3:162288400-162288800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
10	chr3:162291600-162292200	Enhancers	Dnd41	blood
11	chr3:162292200-162295800	Weak transcription	Dnd41	blood
12	chr3:162295000-162295400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr3:162295800-162297200	Enhancers	Dnd41	blood
14	chr3:162297200-162297800	Weak transcription	Dnd41	blood
15	chr3:162298200-162299000	Weak transcription	Dnd41	blood
16	chr3:162299000-162299200	Enhancers	Dnd41	blood
17	chr3:162299200-162302000	Weak transcription	Dnd41	blood
18	chr3:162302000-162305200	Enhancers	Dnd41	blood
19	chr3:162302600-162303600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr3:162302800-162303400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
21	chr3:162303000-162304800	Enhancers	A549	lung
22	chr3:162303600-162304200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
23	chr3:162304200-162304400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr3:162304200-162304600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
25	chr3:162304200-162304600	Enhancers	Rectal Mucosa Donor 31	rectum
26	chr3:162304400-162304800	Enhancers	Fetal Lung	lung
27	chr3:162305200-162305600	Weak transcription	Dnd41	blood
28	chr3:162305600-162305800	Enhancers	Dnd41	blood
29	chr3:162305800-162307600	Weak transcription	Dnd41	blood
30	chr3:162307600-162308400	Genic enhancers	Dnd41	blood
31	chr3:162308400-162308800	Weak transcription	Dnd41	blood
32	chr3:162308800-162310400	Enhancers	Dnd41	blood
33	chr3:162310400-162311400	Weak transcription	Dnd41	blood
34	chr3:162311400-162312800	Genic enhancers	Dnd41	blood
35	chr3:162312800-162314400	Enhancers	Dnd41	blood
36	chr3:162313800-162317200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
37	chr3:162314200-162316400	Enhancers	Brain Substantia Nigra	brain
38	chr3:162314200-162317200	Enhancers	Cortex derived primary cultured neurospheres	brain
39	chr3:162314400-162315200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
40	chr3:162314400-162315800	Flanking Active TSS	Dnd41	blood
41	chr3:162314400-162316400	Enhancers	Brain Hippocampus Middle	brain
42	chr3:162314400-162318800	Weak transcription	HSMM	muscle
43	chr3:162314800-162315200	Enhancers	iPS-20b Cell Line	embryonic stem cell
44	chr3:162314800-162315600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
45	chr3:162314800-162315600	Enhancers	Brain Angular Gyrus	brain
46	chr3:162314800-162316200	Enhancers	Brain Cingulate Gyrus	brain
47	chr3:162314800-162316600	Enhancers	Brain Anterior Caudate	brain
48	chr3:162314800-162316800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
49	chr3:162315000-162315200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr3:162315000-162315600	Enhancers	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links